Iogen Sells Industrial Enzyme Division to Novozymes
Iogen Corp., an Ottawa, Ontario-based biotechnology company announced the sale of its industrial enzyme subsidiary, Iogen Bio-Products, to Danish enzyme manufacturer Novozymes A/S for a purchase price of C$67.5 million and potential earn-out payments of up to C$12.5 million. The transaction is expected to be completed before the end of February, 2013. Iogen is a portfolio company of Canadian venture capital firm BEST Funds, and has since 2000 received financing from other international private equity firms.
6 February 2013•2 mins read
